Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment plans improve vitiligo care.

Facial dark spots can be caused by the sun, genetics, makeup, or medicine, and are diagnosed by patient history and skin tests.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Psychological factors like depression may be more important than zinc, folate, and vitamin B12 levels in causing scalp pain in people with hair loss.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Intermediate hair follicles are a better model for studying hair growth and testing hair loss treatments.

Red spots on fingertips can be a sign of a skin condition linked to gluten sensitivity, treatable with a gluten-free diet.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Topical finasteride helps regrow hair and reduce balding without side effects.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Adiponectin may stimulate hair growth and could be a potential treatment for promoting hair growth.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Acne is an important sign of androgen excess disorders in women.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Recent advances in hair loss treatments show significant progress.

Germany recognizes skin cancer from UV exposure as an occupational disease, emphasizing prevention and care for affected workers.

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.